Loading...
Loading...
Among the 4 tracked institutional investors we monitor, CTSO (CYTOSORBENTS CORP) is held with a combined value of $1.74M across 3,090,818 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.41M. 2 funds reduced their position.
Total Institutional Value
$1.74M
Total Shares Held
3,090,818
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.41M | 0.00% | - |
| 2 | BlackRock, Inc. | $234.58K | 0.00% | -19.9% |
| 3 | STATE STREET CORP | $59.58K | 0.00% | - |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $37.41K | 0.00% | -0.7% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CTSO with a position worth $1.41M, representing 0.00% of their portfolio. In total, 4 institutional investors hold CTSO with a combined value of $1.74M.
Institutional investors hold $1.74M worth of CTSO stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.41M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CTSO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CTSO positions.
Last Close
$5.35
2026-10-21
YTD
-59.2%
15% of 52-week range